Skip to main content

Capital Finance

By Rene Letourneau | 10:04 am | January 06, 2012
Robert Aquino, former CEO of Parkway Hospital in Queens, NY, pleaded guilty earlier this week to bribing former state senator Carl Kruger to obtain his help in keeping the hospital open.
By Stephanie Bouchard | 04:04 pm | January 05, 2012
Independent Living Systems (ILS), a national care management company specializing in long-term care, announced Wednesday that it has completed a strategic recapitalization.
By Chris Anderson | 11:06 am | January 04, 2012
Less than one week after an audit report from accounting firm KPMG voiced its serious doubts about its long term viability, West Penn Allegheny Health System announced regional health insurer Highmark will invest $20 million in the first phase of its redevelopment of Forbes Regional Hospital.
By Stephanie Bouchard | 09:52 am | January 03, 2012
The U.S. Department of Justice announced late last week that GE Healthcare has paid more than $30 million to the government to settle False Claims Act allegations.
By Rene Letourneau | 09:42 am | December 30, 2011
Ascension Health and Alexian Brothers Health System announced Wednesday that the two will merge as of Jan. 1, 2012.
By Stephanie Bouchard | 12:09 pm | December 23, 2011
Healthcare real estate will continue to be a strong investment category in 2012 concludes an analysis by Jones Lang LaSalle, a financial and professional services firm specializing in real estate.
By Rene Letourneau | 10:15 am | December 22, 2011
Thomson Reuters today announced that it has suspended the divestiture process for its healthcare business. The company had revealed plans to sell the division in June.
By Rene Letourneau | 10:11 am | December 15, 2011
Fujifilm Holdings Corporation announced Wednesday that it has entered into a definitive agreement to acquire ultrasound technology firm SonoSite, Inc. for approximately $995 million.
By Stephanie Bouchard | 08:58 am | December 14, 2011
Medical device giant, Medtronic, admits no wrongdoing but has agreed to pay the federal government $23.5 million to settle claims that it paid doctors kickbacks to get them to use its pacemakers and defibrillators.
By Stephanie Bouchard | 04:03 pm | December 12, 2011
A dermatology product manufacturer purchased by pharmaceutical company GlaxoSmithKline in 2009 and its former chief executive are being sued by federal regulators for allegedly defrauding employee shareholders of more than $110 million.